Literature DB >> 28684412

Isoform- and cell type-specific structure of apolipoprotein E lipoparticles as revealed by a novel Forster resonance energy transfer assay.

Eleanna Kara1, Jordan D Marks1, Zhanyun Fan1, Jacob A Klickstein1, Allyson D Roe1, Kelly A Krogh1, Susanne Wegmann1, Masato Maesako1, Christina C Luo2, Ravi Mylvaganam2, Oksana Berezovska1, Eloise Hudry1, Bradley T Hyman3.   

Abstract

Apolipoprotein E (apoE) has an important role in the pathogenesis of Alzheimer's disease with its three isoforms having distinct effects on disease risk. Here, we assessed the conformational differences between those isoforms using a novel flow cytometry-Forster resonance energy transfer (FRET) assay. We showed that the conformation of intracellular apoE within HEK cells and astrocytes adopts a directional pattern; in other words, E4 adopts the most closed conformation, E2 adopts the most open conformation, and E3 adopts an intermediate conformation. However, this pattern was not maintained upon secretion of apoE from astrocytes. Intermolecular interactions between apoE molecules were isoform-specific, indicating a great diversity in the structure of apoE lipoparticles. Finally, we showed that secreted E4 is the most lipidated isoform in astrocytes, suggesting that increased lipidation acts as a folding chaperone enabling E4 to adopt a closed conformation. In conclusion, this study gives insights into apoE biology and establishes a robust screening system to monitor apoE conformation.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Alzheimer's disease; apolipoprotein E (apoE); conformational change; flow cytometry; fluorescence resonance energy transfer (FRET); lipoprotein; neurodegenerative disease

Mesh:

Substances:

Year:  2017        PMID: 28684412      PMCID: PMC5592654          DOI: 10.1074/jbc.M117.784264

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

1.  Apolipoprotein E4 domain interaction occurs in living neuronal cells as determined by fluorescence resonance energy transfer.

Authors:  Qin Xu; Walter J Brecht; Karl H Weisgraber; Robert W Mahley; Yadong Huang
Journal:  J Biol Chem       Date:  2004-03-30       Impact factor: 5.157

2.  Two distal downstream enhancers direct expression of the human apolipoprotein E gene to astrocytes in the brain.

Authors:  S Grehan; E Tse; J M Taylor
Journal:  J Neurosci       Date:  2001-02-01       Impact factor: 6.167

3.  The lipid-associated conformation of the low density lipoprotein receptor binding domain of human apolipoprotein E.

Authors:  C A Fisher; V Narayanaswami; R O Ryan
Journal:  J Biol Chem       Date:  2000-10-27       Impact factor: 5.157

4.  Production and characterization of astrocyte-derived human apolipoprotein E isoforms from immortalized astrocytes and their interactions with amyloid-beta.

Authors:  Masayuki Morikawa; John D Fryer; Patrick M Sullivan; Erin A Christopher; Suzanne E Wahrle; Ronald B DeMattos; Mark A O'Dell; Anne M Fagan; Hilal A Lashuel; Thomas Walz; Kiyofumi Asai; David M Holtzman
Journal:  Neurobiol Dis       Date:  2005 Jun-Jul       Impact factor: 5.996

Review 5.  Apolipoprotein E: structure-function relationships.

Authors:  K H Weisgraber
Journal:  Adv Protein Chem       Date:  1994

6.  Small molecule structure correctors abolish detrimental effects of apolipoprotein E4 in cultured neurons.

Authors:  Hung-Kai Chen; Zhaoping Liu; Anke Meyer-Franke; Jens Brodbeck; Rene D Miranda; James G McGuire; Michael A Pleiss; Zhong-Sheng Ji; Maureen E Balestra; David W Walker; Qin Xu; Dah-eun Jeong; Madhu S Budamagunta; John C Voss; Stephen B Freedman; Karl H Weisgraber; Yadong Huang; Robert W Mahley
Journal:  J Biol Chem       Date:  2011-12-12       Impact factor: 5.157

7.  Structure and functions of human cerebrospinal fluid lipoproteins from individuals of different APOE genotypes.

Authors:  G W Rebeck; N C Alonzo; O Berezovska; S D Harr; R B Knowles; J H Growdon; B T Hyman; A J Mendez
Journal:  Exp Neurol       Date:  1998-01       Impact factor: 5.330

8.  Apolipoprotein-E forms dimers in human frontal cortex and hippocampus.

Authors:  David A Elliott; Glenda M Halliday; Brett Garner
Journal:  BMC Neurosci       Date:  2010-02-20       Impact factor: 3.288

9.  Apolipoprotein E, especially apolipoprotein E4, increases the oligomerization of amyloid β peptide.

Authors:  Tadafumi Hashimoto; Alberto Serrano-Pozo; Yukiko Hori; Kenneth W Adams; Shuko Takeda; Adrian Olaf Banerji; Akinori Mitani; Daniel Joyner; Diana H Thyssen; Brian J Bacskai; Matthew P Frosch; Tara L Spires-Jones; Mary Beth Finn; David M Holtzman; Bradley T Hyman
Journal:  J Neurosci       Date:  2012-10-24       Impact factor: 6.167

10.  Human apolipoprotein E. Role of arginine 61 in mediating the lipoprotein preferences of the E3 and E4 isoforms.

Authors:  L M Dong; C Wilson; M R Wardell; T Simmons; R W Mahley; K H Weisgraber; D A Agard
Journal:  J Biol Chem       Date:  1994-09-02       Impact factor: 5.157

View more
  10 in total

1.  A flow cytometry-based in vitro assay reveals that formation of apolipoprotein E (ApoE)-amyloid beta complexes depends on ApoE isoform and cell type.

Authors:  Eleanna Kara; Jordan D Marks; Allyson D Roe; Caitlin Commins; Zhanyun Fan; Maria Calvo-Rodriguez; Susanne Wegmann; Eloise Hudry; Bradley T Hyman
Journal:  J Biol Chem       Date:  2018-06-27       Impact factor: 5.157

Review 2.  Using human induced pluripotent stem cells (hiPSCs) to investigate the mechanisms by which Apolipoprotein E (APOE) contributes to Alzheimer's disease (AD) risk.

Authors:  Sreedevi Raman; Nicholas Brookhouser; David A Brafman
Journal:  Neurobiol Dis       Date:  2020-02-05       Impact factor: 5.996

3.  Identification of Potential Targets Linked to the Cardiovascular/Alzheimer's Axis through Bioinformatics Approaches.

Authors:  Francisco Andújar-Vera; Cristina García-Fontana; Raquel Sanabria-de la Torre; Sheila González-Salvatierra; Luis Martínez-Heredia; Iván Iglesias-Baena; Manuel Muñoz-Torres; Beatriz García-Fontana
Journal:  Biomedicines       Date:  2022-02-06

Review 4.  Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies.

Authors:  Yu Yamazaki; Na Zhao; Thomas R Caulfield; Chia-Chen Liu; Guojun Bu
Journal:  Nat Rev Neurol       Date:  2019-07-31       Impact factor: 44.711

5.  Apolipoprotein E particle size is increased in Alzheimer's disease.

Authors:  Thomas J Nelson; Abhik Sen
Journal:  Alzheimers Dement (Amst)       Date:  2018-11-13

Review 6.  The Genetic Variability of APOE in Different Human Populations and Its Implications for Longevity.

Authors:  Paolo Abondio; Marco Sazzini; Paolo Garagnani; Alessio Boattini; Daniela Monti; Claudio Franceschi; Donata Luiselli; Cristina Giuliani
Journal:  Genes (Basel)       Date:  2019-03-15       Impact factor: 4.096

7.  Impact of Apolipoprotein E gene polymorphism during normal and pathological conditions of the brain across the lifespan.

Authors:  Diego Iacono; Gloria C Feltis
Journal:  Aging (Albany NY)       Date:  2019-01-24       Impact factor: 5.682

Review 8.  APOE and Alzheimer's disease: advances in genetics, pathophysiology, and therapeutic approaches.

Authors:  Alberto Serrano-Pozo; Sudeshna Das; Bradley T Hyman
Journal:  Lancet Neurol       Date:  2021-01       Impact factor: 44.182

9.  Mitochondria-dependent phase separation of disease-relevant proteins drives pathological features of age-related macular degeneration.

Authors:  Nilsa La Cunza; Li Xuan Tan; Thushara Thamban; Colin J Germer; Gurugirijha Rathnasamy; Kimberly A Toops; Aparna Lakkaraju
Journal:  JCI Insight       Date:  2021-05-10

10.  An integrated genomic approach to dissect the genetic landscape regulating the cell-to-cell transfer of α-synuclein.

Authors:  Eleanna Kara; Alessandro Crimi; Anne Wiedmer; Marc Emmenegger; Claudia Manzoni; Sara Bandres-Ciga; Karishma D'Sa; Regina H Reynolds; Juan A Botía; Marco Losa; Veronika Lysenko; Manfredi Carta; Daniel Heinzer; Merve Avar; Andra Chincisan; Cornelis Blauwendraat; Sonia García-Ruiz; Daniel Pease; Lorene Mottier; Alessandra Carrella; Dezirae Beck-Schneider; Andreia D Magalhães; Caroline Aemisegger; Alexandre P A Theocharides; Zhanyun Fan; Jordan D Marks; Sarah C Hopp; Andrey Y Abramov; Patrick A Lewis; Mina Ryten; John Hardy; Bradley T Hyman; Adriano Aguzzi
Journal:  Cell Rep       Date:  2021-06-08       Impact factor: 9.423

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.